EGFR and colorectal carcinoma: Furthermore, EGF-targeted 5-FU-loaded PLGA NPs were developed to selectively target CRC cells expressing high levels of EGFR and showed higher rates of cytotoxicity and apoptosis and lower rates of tumor growth compared to non-targeted or non-NP treatments [115].